It is our clinical practice to subject cases with ambiguous or ‘mixed’ morphology to MMR testing and occasionally POLE mutation testing, which may render an integrated diagnosis of MMRd or POLE‐mutated endometrioid carcinoma. Here, POLE is linked to endometrioid adenocarcinoma.